8 Books All Aspiring Leaders Should Look Out For In 2021

https://www.topmba.com/mba-programs/8-books-all-aspiring-leaders-should-look-out-2021?utm_campaign=Newsletters&utm_medium=email&_hsmi=110763606&_hsenc=p2ANqtz--gH1CBvWgU8qrSs9-f0DTCu4Hc1kYiOXFRfRuHC9cAU4LWVvX364AB1w54TlWbQok6TPCY8eT-mJDnT60EYLg0MguFHQ&utm_content=110763579&utm_source=hs_email As we look ahead to 2021 with plenty of reasons for optimism, there’s no better time to discover new ideas and develop your own leadership abilities. Add these books to your ‘Zoom bookshelf’, keep them on your bedside table, and devour them excitedly in between online learning sessions. Here are eight books every good leader needs for 2021. Post Corona: From Crisis to Opportunity by Scott Galloway All businesses were affected by the COVID-19 pandemic, but there is a concrete divide between industries that are set to thrive and those that are struggling to survive as a result of the disruption. NYU Business School professor Scott Galloway provides an insight into what’s currently happening across government, big tech, education, and other industries – offering a framework on how to think about the post-pandemic future. Girl Decoded: A Scientist’s Quest to Reclaim Our Humanity by Bringing Emotional Intelligence to Technology by Rana el Kaliouby Artificial intelligence entrepreneur Rana el Kaliouby shares her story of transformation, showing how her experiences have inspired her to lead a technology revolution. She says to lead others and pursue audacious change, we need to be self-aware and draw from our own lives. In Girl Decoded, leaders can learn how to draw from their own experiences, make intentional changes in their lives and infuse more humanity into their work. Conscious Leadership: Elevating Humanity Through Business by John Mackey Whole Foods CEO John Mackey and his co-authors released Conscious Leadership as a follow-up to Conscious Capitalism. This latest installation presents a framework for how leaders drive societal change through their business leadership. John Mackey shares the principles, vision and mindset he’s used to reach the top of the business world—and do plenty of good in the process. The Gumbo Coalition: 10 Leadership Lessons That Help You Inspire, Unite, and Achieve by Marc Morial Marc Morial, former mayor of New Orleans and current president and CEO of the National Urban League says: “To be a great leader, you must be able to unite people from all backgrounds with seemingly competing agendas to come together under a common cause.” He hopes the The Gumbo Coalition will teach others what he has learned, by showing readers what it means to be a leader who can unite voices and create meaningful change. Facebook COO Sheryl Sandberg said: “The book is a fascinating political memoir, it’s also something more: a leadership manual, complete with checklists, tips, and pitfalls to avoid. Marc writes about how to increase your collective power by building consensus, how vital it is to communicate your vision to your team at every step, and how networking done right is about building purposeful and intentional relationships for the common good. “To my mind, that makes The Gumbo Coalition essential reading for people across all sectors – especially business leaders.” Leading Without Authority: How the New Power of Co-Elevation Can Break Down Silos, Transform Teams, and Reinvent Collaboration by Keith Ferrazzi Keith Ferrazzi is an entrepreneur, coach and author of Never Eat Alone details a new principle in his latest book Leading Without Authority: co-elevation. He says co-elevation enables employees at all levels to connect with colleagues, collaborate freely, and inspire their shared growth. Leaders can learn how to use co-elevation in their own organizations to help their teams build trust, manage stress, and improve performance across the entire company. The Power of Habit: Why We Do What We Do in Life and Business by Charles Duhigg Award-winning business reporter Charles Duhigg says to successfully build habits and harness your true potential, you must understand the science behind habits. In The Power of Habit Duhigg shows readers how utilizing this knowledge can help you change your life for the better and for good. Humanocracy: Creating Organizations as Amazing as the People Inside Them by Gary Hamel and Michele Zanini The future of business is still uncertain in these current times, and businesses to be resilient and adaptable to change. In Humanocracy, Hamel and Zanini make a passionate, data-driven argument for excising bureaucracy and replacing it with something better. The co-authors say top-down power structures and bureaucracy slow businesses down and stifle creativity, and their offers a compellingly argued expose on the massive costs of bureaucracy in society. Humanocracys lays out a detailed blueprint for creating organizations that are as inspired and ingenious as the human beings inside them. Unleashed: The Unapologetic Leader’s Guide to Empowering Everyone Around You by Frances Frei Frances Frei is one of the world’s foremost authorities on leadership. In Unleashed, she teams up with Anne Morriss to teach leaders how to dig deep and empower others. Leadership takes grit, toughness, and the ability to motivate others. Frei and Morriss offer advice from top-performing organizations that can help you raise your game as a leader and pull others up along the way.

THE MINIMUM WAGE IN VARIOUS COUNTRIES (STATISTA.COM)

https://www.statista.com/chart/3501/the-countries-with-the-best-minimum-wages/

The Most Innovative Economies in the World

https://www.statista.com/chart/19312/most-innovative-economies-in-the-world/?utm_source=Statista+Global&utm_campaign=08f1f4cb19-All_InfographTicker_daily_COM_AM_KW05_2021_Fr_COPY&utm_medium=email&utm_term=0_afecd219f5-08f1f4cb19-299815833 Cancer research, meat alternatives and smart home technologies are among the major developments of our time. But which countries are world leaders in research and development, patent activity, high-tech density and everything that comes with fostering innovation? A Bloomberg ranking released today shows the most innovative countries by index value. South Korea ranked highest in 2021, after Germany won the ranking in 2020. The East Asian country had been at the helm of the list also from 2014 to 2019. The U.S. ranked 11th, losing three ranks in two years, and exited the top 10 for the first time. The ranking includes factors such as research and development expenditures, the number of domestic patent applications and the number of domestic public high-tech companies. South Korea scored 90.49 out of 100 possible points, as our chart shows. The Netherlands and Denmark were the countries most improved among the top 10, climbing up four and two ranks, respectively.

Here's how much more money you'd have for retirement if you saved $100 a month starting at 25 instead of 35 (Business Insider.com)

Business Insider/Andy Kiersz. Time is the greatest tool we have for building wealth. If two people save $100 a month for retirement, but one starts at 25 and the other starts at 35, the early saver will have nearly twice as much in their bank account by age 65. Starting to save now, wherever you are in your timeline, is better than starting tomorrow or next week. Consider the following example and the chart below. Chris and Jennifer both invest $100 a month at a 5% annual compound rate of return. Chris begins investing at age 25, putting away $100 every month until 65 and Jennifer begins saving $100 a month at age 35. An extra 10 years of saving means that Chris has about $162,000 in his bank account, while Jennifer has $89,000 by the time she is 65. Chris' balance is nearly double Jennifer's, and he contributed only $12,000 more of his own money. Now, if Chris and Jennifer incrementally increase their monthly contribution as they grow older — perhaps bumping up their savings rate by a small percentage with every pay raise — they'll wind up with even more money in that account at retirement. Plus, investing in the stock market, whether directly or through a retirement account such as a 401(k), may yield a rate of return that's even higher than 5% in some years. Historically, the stock market has averaged a 7% rate of return, adjusting for inflation. Saving in a tax-advantaged retirement account, such as an IRA or 401(k), can give your money an even greater boost. Those types of accounts are funded with pretax money, so your full dollar will have the opportunity to compound.

5/2/2021 Η ελληνική Advent Technologies Holdings Inc.εισέρχεται στο NASDAQ

http://www.ictplus.gr/default.asp?pid=30&rID=70280&ct=0&la=1

UK small and medium-size enterprises: Impact of the COVID-19 crisis (mckinsey.com)

https://www.mckinsey.com/industries/public-and-social-sector/our-insights/uk-small-and-medium-size-enterprises-impact-of-the-covid-19-crisis?cid=other-eml-alt-mip-mck&hdpid=48a0365e-9a3a-4317-8827-6f80c42279c0&hctky=11703013&hlkid=309a60a181904f0caeb929e297079cdb

The vaccine news continues to be better than many people realize. by David Leonhardt ( The New York Times Feb 1, 2021)

Infections aren’t what matters The news about the vaccines continues to be excellent — and the public discussion of it continues to be more negative than the facts warrant. Here’s the key fact: All five vaccines with public results have eliminated Covid-19 deaths. They have also drastically reduced hospitalizations. “They’re all good trial results,” Caitlin Rivers, an epidemiologist at Johns Hopkins University, told me. “It’s great news.” Many people are instead focusing on relatively minor differences among the vaccine results and wrongly assuming that those differences mean that some vaccines won’t prevent serious illnesses. It’s still too early to be sure, because a few of the vaccine makers have released only a small amount of data. But the available data is very encouraging — including about the vaccines’ effect on the virus’s variants. “The vaccines are poised to deliver what people so desperately want: an end, however protracted, to this pandemic,” as Julia Marcus of Harvard Medical School recently wrote in The Atlantic. Why is the public understanding more negative than it should be? Much of the confusion revolves around the meaning of the word “effective.” What do we care about? In the official language of research science, a vaccine is typically considered effective only if it prevents people from coming down with any degree of illness. With a disease that’s always or usually horrible, like ebola or rabies, that definition is also the most meaningful one. But it’s not the most meaningful definition for most coronavirus infections. Whether you realize it or not, you have almost certainly had a coronavirus. Coronaviruses have been circulating for decades if not centuries, and they’re often mild. The common cold can be a coronavirus. The world isn’t going to eliminate coronaviruses — or this particular one, known as SARS-CoV-2 — anytime soon. Yet we don’t need to eliminate it for life to return to normal. We instead need to downgrade it from a deadly pandemic to a normal virus. Once that happens, adults can go back to work, and children back to school. Grandparents can nuzzle their grandchildren, and you can meet your friends at a restaurant. As Dr. Ashish Jha, the dean of the Brown University School of Public Health, told me this weekend: “I don’t actually care about infections. I care about hospitalizations and deaths and long-term complications.” The data By those measures, all five of the vaccines — from Pfizer, Moderna, AstraZeneca, Novavax and Johnson & Johnson — look extremely good. Of the roughly 75,000 people who have received one of the five in a research trial, not a single person has died from Covid, and only a few people appear to have been hospitalized. None have remained hospitalized 28 days after receiving a shot. To put that in perspective, it helps to think about what Covid has done so far to a representative group of 75,000 American adults: It has killed roughly 150 of them and sent several hundred more to the hospital. The vaccines reduce those numbers to zero and nearly zero, based on the research trials. Zero isn’t even the most relevant benchmark. A typical U.S. flu season kills between five and 15 out of every 75,000 adults and hospitalizes more than 100 of them. I assume you would agree that any vaccine that transforms Covid into something much milder than a typical flu deserves to be called effective. But that is not the scientific definition. When you read that the Johnson & Johnson vaccine was 66 percent effective or that the Novavax vaccine was 89 percent effective, those numbers are referring to the prevention of all illness. They count mild symptoms as a failure. “In terms of the severe outcomes, which is what we really care about, the news is fantastic,” Dr. Aaron Richterman, an infectious-disease specialist at the University of Pennsylvania, said. The variants What about the highly contagious new virus variants that have emerged in Britain, Brazil and South Africa? The South African variant does appear to make the vaccines less effective at eliminating infections. Fortunately, there is no evidence yet that it increases deaths among vaccinated people. Two of the five vaccines — from Johnson & Johnson and Novavax — have reported some results from South Africa, and none of the people there who received a vaccine died of Covid. “People are still not getting serious illness. They’re still not dying,” Dr. Rebecca Wurtz of the University of Minnesota School of Public Health told me. The most likely reason, epidemiologists say, is that the vaccines still provide considerable protection against the variant, albeit not quite as much as against the original version. Some protection appears to be enough to turn this coronavirus into a fairly normal disease in the vast majority of cases. “This variant is clearly making it a little tougher to get the most vigorous response that you would want to have,” Dr. Francis Collins, director of the National Institutes of Health, said. “But still, for severe disease, it’s looking really good.”